Literature DB >> 26115583

Parenchymal cystatin C focal deposits and glial scar formation around brain arteries in Hereditary Cystatin C Amyloid Angiopathy.

Asbjorg Osk Snorradottir1, Helgi J Isaksson2, Stephan A Kaeser3, Angelos A Skodras4, Elias Olafsson5, Astridur Palsdottir6, Birkir Thor Bragason7.   

Abstract

Hereditary Cystatin C Amyloid Angiopathy (HCCAA) is an amyloid disorder in Icelandic families caused by an autosomal dominant mutation in the cystatin C gene. Mutant cystatin C forms amyloid deposits in brain arteries and arterioles which are associated with changes in the arterial wall structure, notably deposition of extracellular matrix proteins. In this post-mortem study we examined the neuroinflammatory response relative to the topographical distribution of cystatin C deposition, and associated haemorrhages, in the leptomeninges, cerebrum, cerebellum, thalamus, and midbrain of HCCAA patients. Cystatin C was deposited in all brain areas, grey and white matter alike, most prominently in arteries and arterioles; capillaries and veins were not, or minimally, affected. We also observed perivascular deposits and parenchymal focal deposits proximal to affected arteries. This study shows for the first time, that cystatin C does not exclusively form CAA and perivascular amyloid but also focal deposits in the brain parenchyma. Haemorrhages were observed in all patients and occurred in all brain areas, variable between patients. Microinfarcts were observed in 34.6% of patients. The neuroinflammatory response was limited to the close vicinity of affected arteries and perivascular as well as parenchymal focal deposits. Taken together with previously reported arterial accumulation of extracellular matrix proteins in HCCAA, our results indicate that the central nervous system pathology of HCCAA is characterised by the formation of a glial scar within and around affected arteries.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystatin C distribution; Focal deposits; Glial scar; Hereditary Cystatin C Amyloid Angiopathy; Neuroinflammation

Mesh:

Substances:

Year:  2015        PMID: 26115583     DOI: 10.1016/j.brainres.2015.06.019

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy.

Authors:  Asbjorg Osk Snorradottir; Helgi J Isaksson; Saevar Ingthorsson; Elias Olafsson; Astridur Palsdottir; Birkir Thor Bragason
Journal:  Lab Invest       Date:  2017-01-09       Impact factor: 5.662

2.  Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway.

Authors:  Guangna Yu; Xingyuan Sun; Li Li; Lijuan Huang; Hongbin Liu; Shuying Wang; Zhanjun Ren; Yanjiao Zhang
Journal:  Exp Ther Med       Date:  2019-12-31       Impact factor: 2.447

3.  NAC blocks Cystatin C amyloid complex aggregation in a cell system and in skin of HCCAA patients.

Authors:  Michael E March; Alvaro Gutierrez-Uzquiza; Asbjorg Osk Snorradottir; Leticia S Matsuoka; Noelia Fonseca Balvis; Thorgeir Gestsson; Kenny Nguyen; Patrick M A Sleiman; Charlly Kao; Helgi J Isaksson; Birkir Thor Bragason; Elias Olafsson; Astridur Palsdottir; Hakon Hakonarson
Journal:  Nat Commun       Date:  2021-03-23       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.